The announcement of a class action lawsuit against Cardlytics, Inc. is likely to negatively impact the stock price in the short term as it raises legal and financial uncertainties. The involvement of a recognized law firm and the opportunity for investors with substantial losses to lead the lawsuit could amplify investor concerns.